全文获取类型
收费全文 | 3292篇 |
免费 | 294篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 122篇 |
妇产科学 | 131篇 |
基础医学 | 327篇 |
口腔科学 | 115篇 |
临床医学 | 460篇 |
内科学 | 741篇 |
皮肤病学 | 43篇 |
神经病学 | 167篇 |
特种医学 | 248篇 |
外科学 | 575篇 |
综合类 | 77篇 |
一般理论 | 22篇 |
预防医学 | 239篇 |
眼科学 | 12篇 |
药学 | 99篇 |
中国医学 | 5篇 |
肿瘤学 | 184篇 |
出版年
2022年 | 16篇 |
2021年 | 38篇 |
2020年 | 28篇 |
2019年 | 50篇 |
2018年 | 84篇 |
2017年 | 69篇 |
2016年 | 77篇 |
2015年 | 70篇 |
2014年 | 90篇 |
2013年 | 123篇 |
2012年 | 153篇 |
2011年 | 152篇 |
2010年 | 135篇 |
2009年 | 118篇 |
2008年 | 140篇 |
2007年 | 135篇 |
2006年 | 139篇 |
2005年 | 137篇 |
2004年 | 128篇 |
2003年 | 104篇 |
2002年 | 108篇 |
2001年 | 82篇 |
2000年 | 69篇 |
1999年 | 70篇 |
1998年 | 85篇 |
1997年 | 77篇 |
1996年 | 71篇 |
1995年 | 76篇 |
1994年 | 39篇 |
1993年 | 53篇 |
1992年 | 49篇 |
1991年 | 67篇 |
1990年 | 70篇 |
1989年 | 62篇 |
1988年 | 59篇 |
1987年 | 61篇 |
1986年 | 64篇 |
1985年 | 47篇 |
1984年 | 39篇 |
1983年 | 39篇 |
1981年 | 33篇 |
1980年 | 23篇 |
1979年 | 30篇 |
1978年 | 23篇 |
1977年 | 25篇 |
1976年 | 24篇 |
1975年 | 22篇 |
1974年 | 19篇 |
1973年 | 23篇 |
1972年 | 18篇 |
排序方式: 共有3597条查询结果,搜索用时 15 毫秒
1.
M. Manfredi M. J. McCullough Z. M. Al‐Karaawi P. Vescovi S. R. Porter 《Molecular oral microbiology》2006,21(6):353-359
To increase our understanding of Candida pathogenicity, the identification of those strains most frequently associated with infections is of paramount importance. Polymerase chain reaction (PCR)‐based methods are extremely effective in differentiating and determining reproducibility, they require minimum starting material and are rapid and simple to perform. In this study, the genetic relatedness of Candida albicans was assessed for two geographically different patient groups (London, UK and Parma, Italy) affected by diabetes mellitus. C. albicans samples from the oral cavities of non‐diabetic healthy subjects were also examined by PCR fingerprinting to evaluate the possible genetic differences among endogenous strains in individuals with and without diabetes mellitus. PCR fingerprinting, with subsequent phylogenetic analysis of C. albicans isolates from the diabetic patients from London and Italy and from the non‐diabetic subjects, revealed that there were significant differences (P < 0.0001) between C. albicans isolates indicative of the distinct ecological niches that occur in the oral cavities of these patient cohorts. The most diverse group comprised the isolates from the diabetic patients in the UK, possibly reflecting the antifungal treatment that these patients had received. Further studies that include isolates from patient cohorts with systemic diseases other than diabetes mellitus, and from more diverse geographic localities are required to explain the relatedness of C. albicans isolates in the mouth. 相似文献
2.
T. M. Egan S. Murray R. T. Bustami T. H. Shearon K. P. McCullough L. B. Edwards M. A. Coke E. R. Garrity S. C. Sweet D. A. Heiney F. L. Grover 《American journal of transplantation》2006,6(5P2):1212-1227
This article reviews the development of the new U.S. lung allocation system that took effect in spring 2005. In 1998, the Health Resources and Services Administration of the U.S. Department of Health and Human Services published the Organ Procurement and Transplantation Network (OPTN) Final Rule. Under the rule, which became effective in 2000, the OPTN had to demonstrate that existing allocation policies met certain conditions or change the policies to meet a range of criteria, including broader geographic sharing of organs, reducing the use of waiting time as an allocation criterion and creating equitable organ allocation systems using objective medical criteria and medical urgency to allocate donor organs for transplant. This mandate resulted in reviews of all organ allocation policies, and led to the creation of the Lung Allocation Subcommittee of the OPTN Thoracic Organ Transplantation Committee. This paper reviews the deliberations of the Subcommittee in identifying priorities for a new lung allocation system, the analyses undertaken by the OPTN and the Scientific Registry for Transplant Recipients and the evolution of a new lung allocation system that ranks candidates for lungs based on a Lung Allocation Score, incorporating waiting list and posttransplant survival probabilities. 相似文献
3.
4.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
5.
6.
In a prospective, randomized, double-blind study, 49 patients underwent lumbar myelography using iotrol (24 patients) or metrizamide (25 patients). The diagnostic imaging adequacy of iotrol was comparable with that of metrizamide. After iotrol myelography, adverse reactions were fewer, less severe, and of shorter duration than were those following metrizamide myelography. Thirteen of 24 patients (54%) receiving iotrol reported some adverse reactions compared with 24 of 25 patients (96%) receiving metrizamide. Five moderate and one severe adverse reaction occurred in the group receiving iotrol. Fourteen moderate and eight severe adverse reactions occurred in the group receiving metrizamide. Thirty-eight patients underwent electroencephalography both before and after myelography (19 iotrol and 19 metrizamide). None of the EEGs obtained after iotrol myelography changed from baseline, while seven of the EEGs obtained after metrizamide myelography showed changes from baseline. Iotrol was judged superior to metrizamide as a contrast medium in this patient population. 相似文献
7.
8.
D L Cohen L B McCullough R W Kessel A Y Apostolides E R Alden K J Heiderich 《Journal of medical education》1987,62(10):789-798
When medical students become involved in patient care, concerns are raised that have ethical and possibly legal implications. In order to determine compliance with the guidelines of the U.S. government and the Joint Committee on Accreditation of Hospitals pertaining to informed consent, the authors conducted a study of hospital administrators, medical school department chairpersons, and medical school deans (with response rates ranging from 82.3 to 95.1 percent) concerning policies on student involvement in patient care. The results show that only 37.5 percent of all responding teaching hospitals specifically informed patients that students would be involved in care. Only 51 percent of the responding medical schools that specifically gave their students instruction or guidance on initial patient interaction as a matter of policy insisted that their students introduce themselves as students and clarify their role in patient care. The authors conclude that medical educators' compliance with the ethical requirements of informed consent is incomplete. 相似文献
9.
10.